What I do at MMV:
I lead the development of country-specific access initiatives as well as product launch & scale-up plans in Africa in support of MMV's Product Development Teams. I manage advocacy and dissemination of product information through various channels in Africa and am responsible for supporting MMV's severe malaria products: injectable artesunate and intrarectal artesunate. I’m also the Project Lead for MMV's UNITAID grant that supports the uptake of these severe malaria treatments.
Why I work at MMV:
MMV is a great environment to work in. Collaborating with our different pharma partners allows me to apply the experience that I gained working in the pharmaceutical industry. MMV also offers the unique opportunity to work with many different malaria stakeholders (funders, policy makers, implementing partners and pharma partners), in order to achieve our access goals of supporting the introduction and enhancing the reach of new antimalarials.
More about me:
After more than 7 years in the private healthcare sector, I joined MMV in 2010 as Associate Director, Product Development. In 2013 I moved into the role of Director, Access and Delivery Africa. Prior to joining MMV, I worked for Sanofi and GSK in various marketing positions within a regional Sub-Saharan Africa role. Working in the African markets, malaria was always included into my portfolio and I was fortunate enough to launch three new antimalarials during the time spent within these two companies. I also supported the development of antimalarials while at GSK in the UK, working as Product Strategy Manager for Global Product Strategy (GPS), Diseases of the Developing World (DDW). I have a marketing degree and an MBA from Bond University in Australia.
Ask me about:
Working with stakeholders to help support the uptake of new drugs which will save millions of lives, working in Africa, Springbok rugby, and anything about my country as I am a proud South African.
You can also ask me about this African proverb: “If you want to go faster, go alone. If you want to go further, go together.” This saying truly captures the collaborative partnership which we have adopted to support the scale up of injectable artesunate and rectal artesunate to treat severe malaria patients.